Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

<< Previous

Bullboard Posts

Next >>

Post by RReis09on Apr 26, 2021 7:42pm

131 Views

Post# 33071868

CHINA ABQQ On Radar! China Box Office Movies\Video Streaming

Was $20.00 Before Covid! Low Float,Low Mkt Cap,Inside Buying, REVS @ No Stock Promotions Wich=Dillution. Another Box Office Release Across China This Fri! Bet On That NR @ End Of Week))

<< Previous

Bullboard Posts

Next >>

Is China getting serious? Rheinmetall and Almonty Industries profit